Equinor ASA EQNR
42.19
(0.98)
(2.27%)
as of 25 Sep
- Market cap
- $102.3B
- P/E
- 11.5×
Follow EQNR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
11.50 | 12.37 | 19.36 | 8.56 |
P/S ratio |
0.57 | 0.58 | 1.01 | 0.67 | |
P/FCF ratio |
7.54 | 7.27 | 23.32 | 6.23 | |
P/Operating CF |
9.71 | 29.09 | 20.21 | 8.06 | |
P/B ratio |
1.52 | 1.51 | 2.41 | 1.77 | |
Price to Tangible BV |
1.80 | 1.77 | 2.80 | 2.05 | |
EV/Sales |
0.59 | 0.64 | 1.06 | 0.67 | |
EV/EBITDA |
1.59 | 1.80 | 2.90 | 1.73 | |
EV/Operating CF |
3.23 | 3.40 | 6.82 | 3.32 | |
EV/FCF |
7.87 | 8.05 | 24.40 | 6.27 | |
Quick Ratio |
0.93 | 0.98 | 0.89 | 0.92 | |
Current Ratio |
1.48 | 1.27 | 1.24 | 1.18 | |
Net Debt/EBITDA |
0.31 | 0.75 | 0.43 | 0.03 | |
Debt/Assets |
18.46% | 19.73% | 17.67% | 17.21% | |
Debt/Equity |
0.62 | 0.64 | 0.57 | 0.56 | |
Asset Turnover |
0.80 | 0.81 | 0.77 | 0.82 | |
Operating CF/Net income |
(30.22) | 1.60 | 1.68 | 1.95 | |
Capex/Depreciation |
(1.02) | (0.63) | (1.23) | (0.82) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.97% | 1.13% | 0.55% | 0.54% | |
Selling, General and Administrative Expense of Revenue |
0.99% | 1.17% | 1.11% | 0.78% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.70) | (0.85) | (0.49) | (0.69) | |
Graham Number |
27.68 | 25.91 | 29.29 | 38.28 | |
Earnings Yield |
8.70% | 8.08% | 5.17% | 11.69% | |
Free Cash Flow Yield |
13.26% | 13.76% | 4.29% | 16.06% | |
Revenue per Share |
10.31 | 9.78 | 11.16 | 14.47 | |
Operating CF per Share |
2.51 | 0.81 | 2.09 | 3.90 | |
Capex per Share |
(1.35) | (0.82) | (1.25) | (0.92) | |
Free Cash Flow per Share |
1.16 | 0.00 | 0.84 | 2.98 | |
Cash per Share |
8.86 | 7.46 | 8.05 | 9.76 | |
Shareholders Equity per Share |
16.06 | 15.62 | 17.48 | 17.74 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.06 | 15.62 | 17.48 | 17.74 | |
Free Cash Flow |
2,927.00 | (8.00) | 2,097.00 | 7,244.00 | |
Working Capital |
16,946.00 | 8,160.00 | 8,858.00 | 6,806.00 | |
Capital Expenditures |
(3,420.00) | (2,114.00) | (3,116.00) | (2,226.00) | |
Net Current Asset Value |
(43,101.00) | (52,290.00) | (51,606.00) | (52,335.00) | |
EV/EBIT |
2.25 | 2.68 | 4.36 | 2.36 | |
Capex to Sales |
0.13 | 0.08 | 0.11 | 0.06 | |
Net Profit Margin |
(0.81%) | 5.18% | 11.16% | 13.78% | |
Price to Operating Income |
2.15 | 2.42 | 4.17 | 2.35 | |
| Other line items | |||||
Average Receivables |
10,474.50 | 12,204.50 | 11,850.50 | 11,659.00 | |
Average Payables |
9,795.50 | 10,405.00 | 10,537.00 | 10,720.00 | |
Average Inventory |
3,497.00 | 3,680.50 | 3,784.50 | 3,372.50 | |
Average Assets |
135,481.50 | 131,434.00 | 136,440.50 | 139,995.00 | |
Average Common Equity |
42,489.00 | 41,438.50 | 42,069.00 | 42,552.50 |
Columns are period end dates